Yesterday Biogen announced very exciting news at the AD/PD conference: this is the first time a trial for a disease-modifying Alzheimer's drug gives such clearl

Yesterday Biogen announced very exciting news at the AD/PD conference: this is the first time a trial for a disease-modifying Alzheimer's drug gives such clearly positive results. Don't get too excited, this is only phase one so things can still go wrong, but the results are really convincing.